Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psyllium Husk in Pediatric IBS
Sponsor: Eman ElHaddad
Summary
Children aged 6 to 17 years with IBS will be randomly assigned to either receive psyllium husk supplementation in addition to usual care or receive usual care alone. The study will compare gastrointestinal symptoms, quality of life, and gut microbiota between the two groups.
Official title: Psyllium Husk Supplementation in Pediatric Irritable Bowel Syndrome: Effects on Symptoms, Quality of Life and Gut Microbiota
Key Details
Gender
All
Age Range
6 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-10-10
Completion Date
2027-08-15
Last Updated
2026-10-19
Healthy Volunteers
No
Interventions
Psyllium Husk
Psyllium husk supplementation administered in addition to conventional therapy. Children aged 6-12 years will receive 6 g/day (3 g twice daily), while adolescents will receive 12 g/day (6 g twice daily).
Conventional therapy group
Conventional management for pediatric irritable bowel syndrome according to the study protocol, including cognitive behavioral therapy and appropriate pharmacological treatment according to predominant symptoms.